Fintel reports that on April 8, 2025, William Blair initiated coverage of Ocular Therapeutix (NasdaqGM:OCUL) with a Outperform recommendation. Analyst Price Forecast Suggests 195.25% Upside As of ...

A review published in The Laryngoscope indicates that climate change's effects on pollen seasons and concentrations are ...

Asthma management is very personalized. Find out what goes into to an asthma action plan and how medications are prescribed ...

The Big Easy has become the Big Sneezy, jumping to second place in a list of Allergy Capitals released in March by the Asthma and Allergy Foundation of America. Many Southern and Eastern cities carry ...